What Is Venous Stenosis? Causes, Symptoms, and Treatment

Venous stenosis is a narrowing of a vein that restricts or blocks blood from flowing back toward the heart. It can develop in deep veins of the legs, the large central veins inside the chest, or the veins of the upper extremities, and its causes range from blood clots and scar tissue to physical compression by nearby anatomical structures. The condition often goes unrecognized because its symptoms overlap with many other problems, yet when it progresses, it can cause chronic swelling, pain, skin damage, and significant disability.

How Veins Narrow

A vein can lose its normal diameter through several mechanisms. In many cases, especially after a deep vein thrombosis (DVT), the body’s healing process leaves behind fibrous scar tissue inside the vessel wall. That scar tissue stiffens the vein and permanently reduces its opening. In other cases, something outside the vein physically squeezes it, such as a nearby artery or a bony structure. A third pathway involves the overgrowth of cells in the vein wall itself, a process researchers call neointimal hyperplasia, which is particularly common in veins that have been subjected to surgical connections or the turbulent blood flow created by dialysis access sites.

Neointimal hyperplasia is the leading cause of vein narrowing in people who depend on hemodialysis, where an artery and vein are surgically connected to allow blood to be filtered by a machine. The high-pressure, turbulent flow at that junction triggers smooth muscle cells in the vein wall to multiply and produce excess connective tissue, gradually choking off the opening.¹ Effective treatments for this type of narrowing remain limited, partly because the biology behind it is still not fully understood.

Common Causes

Venous stenosis is not one disease with one cause. The trigger depends on which veins are affected and what has happened to the patient. Several distinct causes account for most cases.

Indwelling Catheters and Implanted Devices

Catheters placed in the large central veins for dialysis, chemotherapy, or long-term intravenous medications are a major cause of central venous stenosis. The catheter irritates the vein wall, triggering inflammation and the formation of a fibrin sheath that gradually thickens into scar tissue. Animal models have demonstrated dramatic increases in the inner wall thickness of veins exposed to catheters, along with extensive collagen buildup and activation of fibrotic signaling pathways.² This type of injury has historically been reported most often with subclavian vein catheters, but systematic imaging studies have confirmed it also occurs with internal jugular vein catheters used for tunneled dialysis access.³

Pacemaker and defibrillator leads cause a similar problem. The wires sit permanently inside the subclavian or brachiocephalic veins, and their presence can provoke enough wall injury and scarring to create clinically significant stenosis. This becomes a particular concern for dialysis patients who also have cardiac devices, because the narrowing can interfere with the functioning of a dialysis fistula on the same side of the body.⁴

Anatomical Compression Syndromes

Some people develop venous stenosis because of how their blood vessels and bones are arranged. The best-known example is May-Thurner syndrome, in which the right common iliac artery crosses over and presses the left common iliac vein against the spine. That compression narrows the vein and predisposes the person to DVT in the left leg.⁵ While most people with this anatomical variant never develop symptoms, those who do can experience significant left leg pain, swelling, and clotting.⁶

A similar compression scenario plays out in the upper body in venous thoracic outlet syndrome, where the subclavian vein is squeezed between the collarbone and the first rib. This can lead to arm swelling, pain, and clotting.⁷ Compression of the internal jugular vein by surrounding structures is another recognized variant, though it is less common and has only recently gained attention as a treatable condition.⁸

Post-Thrombotic Scarring

After a DVT, the body dissolves some of the clot but often leaves behind residual scar tissue and damaged vein valves. Over time, this remodeling can create a permanently narrowed channel, sometimes called post-thrombotic stenosis. People who had more extensive or recurrent clots tend to develop more severe narrowing. The inflammatory response that accompanies clot formation, in which immune cells and the clotting system amplify each other, plays a central role in the vein wall damage that leads to scarring. Venous stenting has become the preferred treatment when post-thrombotic stenosis causes significant symptoms.⁹

What It Feels Like

Symptoms depend heavily on which vein is narrowed and how much blood flow is blocked. Many cases of venous stenosis cause no symptoms at all, especially when the body has had time to develop collateral veins that reroute blood around the obstruction. When symptoms do appear, they tend to fall into patterns based on location.

In the legs, the hallmark is chronic swelling that worsens throughout the day and improves overnight. The affected leg may feel heavy, tight, or achy, especially after prolonged standing. Skin changes can develop over months or years, including darkening of the skin around the ankle, thickening and hardening of the tissue, and in advanced cases, venous ulcers that are notoriously difficult to heal.

A particularly disabling symptom is venous claudication, a bursting, tight pain in the thigh or calf that comes on during walking and forces the person to stop. Unlike arterial claudication, which results from insufficient blood flowing in, venous claudication results from blood being unable to flow out efficiently. Research has shown that in affected limbs, venous pressure takes dramatically longer to return to resting levels after exercise compared with healthy limbs.¹⁰ The buildup of pressure in the tissue creates swelling within the muscle compartment, starving it of oxygen and producing the characteristic pain. One study found that roughly two-thirds of patients with documented venous outflow obstruction experienced incapacitating venous claudication prior to treatment.¹¹

In the upper body, central venous stenosis from catheters or devices typically shows up as swelling of the arm, neck, or face on the affected side. In dialysis patients, this can cause the arm with the dialysis fistula to swell severely, and the fistula itself may stop working properly. High recirculation rates during dialysis and prolonged bleeding at needle sites after treatment are common signs that central venous stenosis is compromising the access circuit.¹² The narrowing of major chest veins can also limit options for creating new dialysis access in the future, a serious problem for patients who will need lifelong treatment.¹³

How It Is Diagnosed

Diagnosing venous stenosis can be tricky because symptoms are nonspecific and the veins involved are often deep inside the body. The workup usually starts with a clinical exam and duplex ultrasound, which can detect narrowing in accessible veins like those in the legs or arms. But for deeper veins, especially the iliac veins in the pelvis and the central veins in the chest, more advanced imaging is needed.

CT venography, in which contrast dye is injected and a CT scan tracks its flow through the veins, provides a detailed map of where narrowing and blockages exist. In studies comparing CT venography with traditional catheter-based venography, CT was found to be especially useful for evaluating the extent of long blockages and detecting associated clots. In about half of patients studied, CT venography findings changed the treatment plan that had been made based on catheter venography alone.¹⁴

Intravascular ultrasound (IVUS) has emerged as the most accurate tool for assessing iliac vein stenosis. During this procedure, a tiny ultrasound probe is threaded inside the vein itself, giving a cross-sectional view of the vessel from the inside. Head-to-head comparisons have shown that conventional venography misses the existence of a lesion entirely in about one in five limbs and fails to identify the exact location of the worst narrowing in more than two-thirds of cases.¹⁵ IVUS also consistently measures stenosis as more severe than venography does, which matters because underestimating the degree of narrowing can lead to undertreating the problem. For these reasons, IVUS has become the standard during procedures to stent iliac vein disease.

Treatment Options

Treatment ranges from conservative management to minimally invasive procedures to open surgery, depending on the severity of symptoms, the location and cause of the stenosis, and the patient’s overall health.

Conservative Measures

Compression stockings, leg elevation, exercise, and medication to manage swelling are the starting point for many patients with mild venous stenosis in the legs. These approaches do not fix the narrowed vein, but they can keep symptoms manageable for a long time. Patients with symptomatic iliofemoral stenosis are typically offered intervention only after conservative therapy has failed to provide adequate relief.¹⁶

Balloon Angioplasty

Angioplasty involves threading a catheter into the narrowed vein and inflating a balloon to stretch the opening. For central venous stenosis in dialysis patients, plain balloon angioplasty has been the go-to treatment for decades. The problem is that the vein often narrows again within months, requiring repeated procedures. Drug-coated balloons, which deliver anti-scarring medication directly to the vein wall during inflation, are being explored as a way to keep the vein open longer. These coated balloons are already used for dialysis access stenosis and are under investigation for other venous locations as well.¹⁷

Venous Stenting

Stenting places a metal scaffold inside the vein to hold it open after angioplasty. For years, doctors used arterial stents off-label in veins because no dedicated venous stents existed. Veins are different from arteries: they are thinner-walled, more flexible, and subject to external crushing forces rather than internal pressure. Purpose-built venous stents that are designed to resist compression while remaining flexible enough to move with the body have only recently become available.

The results with these dedicated stents have been encouraging. A pivotal trial of one such device in patients with symptomatic iliac vein obstruction reported roughly 88% of stents remaining open at one year, with low complication rates and clinically meaningful improvements in pain, swelling, and quality of life scores.¹⁸ Another study looking at the same stent system for superior vena cava syndrome, where a major chest vein is blocked, found that all patients with follow-up experienced significant symptom improvement, with primary patency around 93%.¹⁹ A different dedicated venous stent showed primary patency of about 86% at one year and roughly 98% at two years for central venous occlusive disease, with reintervention for symptomatic restenosis being rare.²⁰

Long-term data show that the underlying cause of stenosis affects how well stents hold up over time. In a large follow-up study, severe re-narrowing inside the stent (greater than 50%) occurred in about 10% of limbs with post-thrombotic disease over six years, but in only about 1% of limbs where the stenosis was nonthrombotic.²¹ Having a clotting disorder by itself did not increase the risk of stent failure, but having had prior extensive clotting did.

Surgical Decompression and Bypass

When the cause of stenosis is external compression, removing the compressing structure can be more effective than stenting alone. In venous thoracic outlet syndrome, thoracic outlet decompression, which involves removing the first rib and releasing tight muscles around the vein, is a well-established approach. This operation has been shown to be safe even in patients who have a dialysis fistula on the same arm.²² For patients with complete central venous occlusion that cannot be opened with catheters and stents, surgical venous bypass using vein grafts can restore flow. In one series, about 93% of patients remained symptom-free at follow-up after bypass, though the procedure carries meaningful risks including graft clotting and wound complications.²³

Surgical decompression of the internal jugular vein is a newer concept, applied in selected patients whose vein is compressed by nearby muscles or bony structures and who have not responded to stenting or other approaches.⁸

Life After a Venous Stent

Having a stent placed in a vein is not the end of treatment. Because veins are a lower-pressure system than arteries and blood moves more slowly through them, stented veins are at ongoing risk of clotting. Most patients are placed on some combination of blood thinners after their procedure, though the ideal regimen and duration remain surprisingly unsettled. The evidence base for post-venous-stent anticoagulation is thin compared with arterial stenting, and practice varies considerably between centers.²⁴

Follow-up imaging, typically with duplex ultrasound, is used to monitor stent patency in the months after placement. If a stent begins to narrow, it can often be treated with repeat angioplasty before it clots completely, which is why the “primary-assisted patency” rates reported in trials are often higher than the straight primary patency rates. Catching a restenosis early and re-opening it is far easier than dealing with a fully thrombosed stent.

Compression stockings usually remain part of the routine, especially for patients with post-thrombotic disease. Even with a perfectly functioning stent restoring outflow through the major veins, the smaller veins and valves downstream may still be damaged, meaning some degree of venous insufficiency persists.

Why Venous Disease Has Lagged Behind Arterial Disease

If you have the impression that far more research, technology, and clinical attention have gone into arterial problems like coronary artery disease and peripheral artery disease than into venous disease, you are right. For decades, the venous system was treated as a low-priority afterthought. Dedicated venous stents only began arriving in clinical practice in the mid-2010s, long after arterial stenting had become routine. The slow pace was partly cultural: venous disease was seen as less life-threatening than arterial blockages, even though chronic venous insufficiency causes substantial disability. It was also partly technical: the venous system’s low pressure, high compliance, and susceptibility to external compression create engineering challenges that are different from anything faced in arterial stent design.

That landscape is shifting. The recent availability of purpose-built venous stents, the growing use of IVUS to more accurately identify stenosis, and increasing recognition of compression syndromes like May-Thurner syndrome have all accelerated the field. Still, large gaps remain. Long-term randomized trials comparing different venous stents, or comparing stenting with conservative management, are mostly lacking. The optimal drug regimen after venous stenting is guided more by expert opinion than by robust trial data. And the biology of why veins scar and re-narrow after treatment remains only partially understood, limiting the ability to prevent restenosis.¹ For patients dealing with venous stenosis today, the tools available are considerably better than they were a decade ago, but the field is still catching up to the sophistication that arterial medicine achieved years earlier.